| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/04/2006 | EP1560589B1 Novel complexes of fatty acid esters of polyhydroxyalkanes and niacinamide |
| 10/04/2006 | EP1558227B1 Injectable 2,6-diisopropylphenol-containing anesthetic composition and methods |
| 10/04/2006 | EP1545206A4 Compositions and products containing enantiomeric equol, and methods for their making |
| 10/04/2006 | EP1534658A4 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 10/04/2006 | EP1531792A4 Abuse-resistant opioid dosage form |
| 10/04/2006 | EP1515966A4 Hydroxy pyranone derivative and preparation method thereof |
| 10/04/2006 | EP1513840B1 Compounds and compositions for the treatment of diabetes and diabetes-related disorders |
| 10/04/2006 | EP1507527A4 Methods for enhancing motor performance and/or endurance |
| 10/04/2006 | EP1492786B1 Pyridinoylpiperidines as 5-ht1f agonists |
| 10/04/2006 | EP1487831B1 Difurylglycolic acid tropenol esters used as anticholinesterase drugs |
| 10/04/2006 | EP1482951B1 Alpha-hydroxy-2-methylene-10-nor-pregnacalciferol and its uses |
| 10/04/2006 | EP1482936B1 Ophthalmic composition comprising ascomycin |
| 10/04/2006 | EP1478373B1 Pharmaceutical compositions comprising one or more steroids one or more tetrahydrofolate components and vitamin b12 |
| 10/04/2006 | EP1467622A4 Mitocidal compositions and methods |
| 10/04/2006 | EP1458376B1 Darifenacin for use in the treatment of urgency induced by overactive bladder |
| 10/04/2006 | EP1455603B1 Stimulation of in vivo production of proteins with formulation comprising leucine |
| 10/04/2006 | EP1453783B1 Substituted aryl-cycloalkanes, and use thereof as anticancer agents |
| 10/04/2006 | EP1451194B1 Preparation of levofloxacin hemihydrate |
| 10/04/2006 | EP1425008B1 Use of substituted aminomethyl chromans in the treatment of side effects of neuroleptics |
| 10/04/2006 | EP1423392B1 Derivatives of morphine-like opioid compounds |
| 10/04/2006 | EP1420799B1 Use of atazanavir in hiv therapy |
| 10/04/2006 | EP1409481B1 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 10/04/2006 | EP1406900B1 Novel compounds, their preparation and use |
| 10/04/2006 | EP1395266B1 Use of antiviral nucleoside derivatives for the manufacture of a medicament for the treatment of hepatitis c infections |
| 10/04/2006 | EP1392695B1 Triazolopyrimidines |
| 10/04/2006 | EP1385840B1 Sulfonamides |
| 10/04/2006 | EP1377290B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 10/04/2006 | EP1372653B1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 10/04/2006 | EP1368019B1 Esmolol formulation |
| 10/04/2006 | EP1354602B1 Medicinal compositions containing diuretic and insulin resistance-improving agent |
| 10/04/2006 | EP1349541B1 Self emulsifying lipid matrix (selm) |
| 10/04/2006 | EP1341520B1 Antibiotic/benzoyl peroxide dispenser |
| 10/04/2006 | EP1341515B1 Water-free skin care formulations comprising micronized urea and method of manufacturing the same |
| 10/04/2006 | EP1322621B1 New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
| 10/04/2006 | EP1289530B1 Lipids for modulating immune response |
| 10/04/2006 | EP1259225B1 Process of dehydration/rehydration for making liposomes |
| 10/04/2006 | EP1255827B1 Oligonucleotides and their use for modulating the expression of tyrosinase involved in the synthesis of melanic pigments |
| 10/04/2006 | EP1253945B1 Ace inhibitor-vasopressin antagonist combinations |
| 10/04/2006 | EP1232171B1 Method of preparing clarithromycin |
| 10/04/2006 | EP1220672B1 Medicament for treatment of neuropathies |
| 10/04/2006 | EP1206942B1 Water channel opener compositions and medicinal compositions for ophthalmic use |
| 10/04/2006 | EP1202746B1 Nsaid and egfr kinase inhibitor containing composition for the treatment or inhibition of colonic polyps and colorectal cancer |
| 10/04/2006 | EP1174137B1 Patches containing buprenorphine hydrochloride |
| 10/04/2006 | EP1135513B1 Adenovirus-mediated gene therapy |
| 10/04/2006 | EP1119361A4 Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities |
| 10/04/2006 | EP1109918B1 Mitogen- and stress-activated protein kinases that contain two kinase domains and uses thereof |
| 10/04/2006 | EP1097382B1 Imidazoline receptor binding compounds |
| 10/04/2006 | EP1027047B1 Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation |
| 10/04/2006 | EP0906091B1 Amidinohydrazones as protease inhibitors |
| 10/04/2006 | EP0898568B1 1-(4-piperidyl)-benzimidazoles having neurotrophic activity |
| 10/04/2006 | EP0893446B1 Cephem compounds and drugs containing the compounds |
| 10/04/2006 | EP0841925B1 Endothelin receptor antagonists |
| 10/04/2006 | EP0651637B1 Control of wound scar production with calmodulin inhibitors or protein kinase c inhibitors |
| 10/04/2006 | CN1842594A Inhibition of apoptosis-specific elF-5A ('elF-5Al') with antisense oligonucleotides and siRNAs as anti-inflammatory therapeutics |
| 10/04/2006 | CN1842536A Glycoside having 4-methylergost-7-en-3-ol skeleton and drug for ameliorating hyperglycemia |
| 10/04/2006 | CN1842532A Pyrimidothiophene compounds |
| 10/04/2006 | CN1842531A Crystal of 1-methyl carbapenem compound |
| 10/04/2006 | CN1842530A Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same |
| 10/04/2006 | CN1842529A Compounds and compositions as protein kinase inhibitors |
| 10/04/2006 | CN1842527A Paroxetine cholate or cholic acid derivative salts, and composition comprising paroxetine and cholic acid or chlolic acid derivatives |
| 10/04/2006 | CN1842526A Benzodiazepine CGRP receptor antagonists |
| 10/04/2006 | CN1842525A Barium salt of benzimidazole derivative |
| 10/04/2006 | CN1842524A 2-substituted benzimidazole derivatives as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 10/04/2006 | CN1842522A Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 10/04/2006 | CN1842520A 1h-imidazole derivatives as cannabinoid receptor modulators |
| 10/04/2006 | CN1842517A 芴衍生物 Fluorene derivatives |
| 10/04/2006 | CN1842349A Gene therapy for skin diseases using needle free syringe |
| 10/04/2006 | CN1842348A Galactomannans and/or glucomannans for increasing the bioavailability of active substances |
| 10/04/2006 | CN1842341A Active fraction having anti-cancer and anti-metastic activity isolated from leaves and stems of ginseng |
| 10/04/2006 | CN1842338A Use of lornoxicam or lornoxicam analogue compounds |
| 10/04/2006 | CN1842337A Stable 5,10-methylene-tetrahydrofolate pharmaceutical compounds |
| 10/04/2006 | CN1842336A Aryloxy and arylalkyleneoxy substituted imidazoquinolines |
| 10/04/2006 | CN1842335A Ophthalmic compositions for treating ocular hypertension |
| 10/04/2006 | CN1842334A Use of a compound in the treatment of sleep disorders |
| 10/04/2006 | CN1842333A Sustained release tablet for oral use |
| 10/04/2006 | CN1842332A Compounds, compositions and methods |
| 10/04/2006 | CN1842331A Novel solid pharmaceutical composition comprising amisulpride |
| 10/04/2006 | CN1842330A Glycosidase inhibitors and methods of synthesizing same |
| 10/04/2006 | CN1842329A Preventive or ameliorating agent for liver disease involving hepatopathy |
| 10/04/2006 | CN1842328A Alpha-aminoamide derivatives useful as anti-inflammatory agents |
| 10/04/2006 | CN1842327A Therapeutic/preventive agent for osteoporosis containing as component isotaxiresinol derived from taxus yunnanensis |
| 10/04/2006 | CN1842326A Suppressant of toxicity induced by cancer chemotherapeutic agent and composition of cancer chemotherapeutic agent containing the same |
| 10/04/2006 | CN1842324A Pharmaceutical composition with improved solubility and fluidity |
| 10/04/2006 | CN1842323A Method of treating ischemia-reperfusion injury |
| 10/04/2006 | CN1842318A Use of biotin or a biotin derivative for lightening skin and treating age spots |
| 10/04/2006 | CN1842277A Infant formula |
| 10/04/2006 | CN1842274A Anhydrous silver dihydrogen citrate compositions |
| 10/04/2006 | CN1841066A Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 10/04/2006 | CN1840659A Method of treating endotoxemia |
| 10/04/2006 | CN1840547A Method for preparing hydroxyethyl starch with different molecular weight and different substitution degree |
| 10/04/2006 | CN1840539A Salangane saponin and preparation method and use thereof |
| 10/04/2006 | CN1840538A 1-(2'-deoxy-2'-fluoro-3'-O-amino acid ester-beta-L-furyl arabinosyl)-5-methyl uracil and its application |
| 10/04/2006 | CN1840529A Process for preparing an anticholinergic |
| 10/04/2006 | CN1840527A Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 10/04/2006 | CN1840205A Transgene mouse model of poly glumine disease, its culturing method and medicine for treating the disease |
| 10/04/2006 | CN1840203A Oligonucleotide drug for preventing and treating influenza virus infection |
| 10/04/2006 | CN1840201A Polyethylene glycol prodrug of gambogicacid, its preparation method, formulation and use |
| 10/04/2006 | CN1840199A Amphiphilic tri-block copolymer-paclitaxel bonded drug and preparation method thereof |
| 10/04/2006 | CN1840196A Dispersible preparation adaptable to indissoluble drug |
| 10/04/2006 | CN1840195A A synergistic pharmaceutical combination for the prevention or treatment of diabetes |